| Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis A Ceribelli, M Fredi, M Taraborelli, I Cavazzana, F Franceschini, ... Arthritis research & therapy 14, 1-6, 2012 | 171 | 2012 |
| Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome E Nuri, M Taraborelli, L Andreoli, M Tonello, M Gerosa, A Calligaro, ... Immunologic research 65, 17-24, 2017 | 145 | 2017 |
| Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies A Ceribelli, I Cavazzana, M Taraborelli, S Zingarelli, F Franceschini The Journal of rheumatology 38 (7), 1329-1334, 2011 | 121 | 2011 |
| Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis A Ceribelli, M Fredi, M Taraborelli, I Cavazzana, A Tincani, C Selmi, ... Clin Exp Rheumatol 32 (6), 891-7, 2014 | 119 | 2014 |
| Antiphospholipid syndrome M Khamashta, M Taraborelli, S Sciascia, A Tincani Best practice & research Clinical rheumatology 30 (1), 133-148, 2016 | 110 | 2016 |
| Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study M Taraborelli, V Ramoni, A Brucato, P Airò, G Bajocchi, F Bellisai, D Biasi, ... Arthritis & Rheumatism 64 (6), 1970-1977, 2012 | 107 | 2012 |
| Antiphospholipid antibodies and malignancies A Tincani, M Taraborelli, R Cattaneo Autoimmunity reviews 9 (4), 200-202, 2010 | 102 | 2010 |
| Longterm outcome of patients with primary antiphospholipid syndrome: a retrospective multicenter study M Taraborelli, R Reggia, F Dall’Ara, M Fredi, L Andreoli, M Gerosa, ... The Journal of rheumatology 44 (8), 1165-1172, 2017 | 72 | 2017 |
| Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years M Taraborelli, I Cavazzana, N Martinazzi, MG Lazzaroni, M Fredi, ... Lupus 26 (11), 1197-1204, 2017 | 71 | 2017 |
| The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus M Taraborelli, L Leuenberger, MG Lazzaroni, N Martinazzi, W Zhang, ... Lupus 25 (12), 1365-1368, 2016 | 54 | 2016 |
| Primary biliary cirrhosis-related autoantibodies in a large cohort of Italian patients with systemic sclerosis I Cavazzana, A Ceribelli, M Taraborelli, M Fredi, G Norman, A Tincani, ... The Journal of rheumatology 38 (10), 2180-2185, 2011 | 53 | 2011 |
| Rare autoantibodies to cellular antigens in systemic lupus erythematosus M Fredi, I Cavazzana, M Quinzanini, M Taraborelli, S Cartella, A Tincani, ... Lupus 23 (7), 672-677, 2014 | 49 | 2014 |
| Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus V Caneparo, T Cena, M De Andrea, V Dell'Oste, P Stratta, M Quaglia, ... Lupus 22 (6), 607-613, 2013 | 48 | 2013 |
| Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges L Andreoli, C Bazzani, M Taraborelli, R Reggia, A Lojacono, A Brucato, ... Autoimmunity reviews 10 (1), 51-54, 2010 | 46 | 2010 |
| Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of … F Scanzi, L Andreoli, M Martinelli, M Taraborelli, I Cavazzana, ... Immunologic research 65, 150-156, 2017 | 44 | 2017 |
| Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of … M Taraborelli, L Andreoli, S Archetti, M Ferrari, R Cattaneo, A Tincani Clinical and experimental rheumatology 27 (3), 499-502, 2009 | 43 | 2009 |
| A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies I Cavazzana, M Fredi, M Taraborelli, M Quinzanini, A Tincani, ... Clin Exp Rheumatol 31 (2 Suppl 76), 118-21, 2013 | 37 | 2013 |
| Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? M Taraborelli, F Inverardi, M Fredi, A Ceribelli, I Cavazzana, A Tincani, ... Reumatismo 64 (5), 321-325, 2012 | 36 | 2012 |
| Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a ‘systemic disease’ M Taraborelli, L Andreoli, A Tincani Best Practice & Research Clinical Rheumatology 26 (1), 79-90, 2012 | 35 | 2012 |
| Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events M Taraborelli, E Sciatti, I Bonadei, V Terlizzi, M Fredi, R Zani, G Cancarini, ... Arthritis Care & Research 70 (9), 1277-1283, 2018 | 32 | 2018 |
